Latest papers

[Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

Question: Should patients who have a significant increase in BUN or creatinine (more than 30% above baseline) in response to an ACEI or ARB be tested for renal stenosis?

Direct renin inhibition and the kidney.

Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.

Biomechanics of resistance artery wall remodeling in angiotensin-II hypertension and subsequent recovery.

Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension.

Juxtaglomerular cell tumor--a rare cause of secondary hypertension.

The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses.

Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.

Overweight, obesity and metabolic alterations in chronic kidney disease.

Hypertension: New treatment target for systolic blood pressure?

[Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats].

Evidence that blood pressure remains under the control of arterial baroreceptors in renal hypertensive rats.

Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.

Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension.

Compression of the left renal artery and celiac trunk by diaphragmatic crura.

Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2.

The pathogenesis and treatment of chronic allograft nephropathy.

Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease.

Long-term renal function and cardiovascular disease risk in obese kidney donors.